Heart Palpitations: Causes, Warning Signs and Rhythm Assessment

Direct answer. Heart palpitations are an unusually noticeable heartbeat: racing, fluttering, pounding or apparently skipped or extra beats. The sensation does not identify a rhythm disorder. NHS 2026 guidance advises emergency help for ongoing palpitations that do not settle or palpitations with chest pain, breathlessness or faintness; if those concerning symptoms have stopped, obtain urgent clinical advice. Confidence is high in the symptom-versus-diagnosis distinction. NHS palpitations, reviewed March2026.

Evidence summary

Confidence is high that this symptom needs a cause-based clinical assessment; its cause cannot be diagnosed from this article. The treatment section attributes clinical guidance; it does not certify the funding of every underlying intervention trial. Independent comparative outcome certainty and a supplement replacement regimen were not established by this focused review. A public institution or independent review cannot make a sponsored original trial financially independent.

What it is

A heartbeat may become noticeable in the chest, neck or throat. People may describe racing, thumping or a missed beat. These descriptions are useful to record but do not reliably name the electrical event. Even a word such as “irregular” in a personal description is different from an ECG-confirmed rhythm diagnosis. NHS palpitations, reviewed March2026.

An arrhythmia involves the heart’s electrical timing. Some arrhythmias are detected without a person noticing symptoms. Conversely, feeling a heartbeat does not by itself establish a dangerous arrhythmia. That distinction prevents both treating every sensation as an emergency diagnosis and dismissing an important recorded rhythm simply because it felt mild. NHLBI arrhythmias; NHLBI arrhythmia symptoms.

How it works

Electrical signals ordinarily coordinate the heartbeat. Changes in signal production or conduction can produce an abnormal rhythm. A person’s perception of the beat is a separate part of the experience, so its intensity cannot substitute for a recording. The same broad word “palpitations” can therefore appear in people whose underlying findings differ substantially. NHLBI arrhythmia causes.

Exercise, lack of sleep, stress, medicines, caffeine, nicotine, alcohol and other substances can be relevant. Thyroid disease, anaemia and heart conditions may also contribute. These are possibilities for a clinical history, not a checklist that can establish which one caused the symptom. Several factors can coexist. NHS palpitations, reviewed March2026.

Family history can change the questions a clinician asks, particularly when a relative has an inherited rhythm disorder or had cardiac arrest. A family history does not mean that every palpable beat represents the same condition. Give the actual diagnosis or circumstances when known rather than relying only on a broad phrase such as “heart trouble.” NHLBI arrhythmia diagnosis.

The evidence-based treatments

The first task is to clarify the cause and clinical importance. Some palpitations require no specific rhythm treatment; others lead to management of an identified condition. A medicine that corrects an underlying problem, one that controls heart rate and a procedure directed at an electrical pathway have different targets. A symptom label alone does not choose between them. NHS palpitations, reviewed March2026.

For a diagnosed arrhythmia, public education describes medicines, cardioversion, ablation and implanted devices. The appropriate choice depends on the actual rhythm, associated disease and treatment goal. These categories are attributed clinical context, not a ranking of interventions for any reader reporting fluttering. The old general source is not treated as an exhaustive current device or drug menu. NHLBI arrhythmia treatment.

A review may instead identify a medicine effect, thyroid disorder or an electrolyte problem. Tell the clinician about recent changes, illness or vomiting as well as the usual product list. Do not stop a prescribed drug independently: the reason for it and the safest replacement, if one is needed, belong in the same discussion. NHLBI arrhythmia causes.

An assessment that recommends observation should explain why, what has been evaluated and what change warrants contact. “No treatment today” can be a deliberate decision, but it should not leave the person uncertain about a later episode. Ask whether the next goal is documenting a rhythm, checking another cause or reviewing symptom burden.

Supplement and lifestyle evidence

No retail supplement is established here as a universal treatment for palpitations. NHLBI distinguishes clinician treatment of a documented low electrolyte level from general rhythm care. That distinction does not support automatically taking potassium or magnesium whenever the heartbeat is noticeable. A product dose should not be inferred from a mechanism or a promotional testimonial. NHLBI arrhythmia treatment.

A clinician may discuss avoidable triggers and sleep, smoking or alcohol habits. A simple symptom record can help that conversation without claiming that a lifestyle change proved a diagnosis. Relief after reducing caffeine does not establish what an uncaptured episode was, and continuing symptoms deserve the agreed review. NHLBI living with arrhythmia.

What works and what does not

Record the time, duration, activity and associated symptoms when it is safe to do so. Note whether onset and ending seemed sudden and whether you felt faint or had chest discomfort. The aim is an accurate history for the service, not a score that authorizes self-treatment. An emergency call comes before building a complete log. NHLBI arrhythmia symptoms.

If a wearable captured an event, ask how to share the original recording and its time stamp. A device alert or pulse number is a clue for clinical interpretation; it should not determine a medicine change by itself. A readable record of the event may answer a different question from a photograph of the device’s summary label.

Do not deliberately provoke another episode with stimulants, intense exertion or breath-holding to obtain proof. A clinician can decide whether supervised testing is appropriate. The absence of a symptom during a short consultation also does not erase the history of an intermittent event; explain what happened and how often. NHLBI arrhythmia diagnosis.

Risks and side effects

Use the emergency pathway for unsettled ongoing palpitations or the associated warning symptoms described above. If concerning symptoms have ended, NHS advises urgent assessment rather than ignoring the episode. Use the corresponding local service outside England, and avoid driving yourself during an event with faintness or suspected serious illness. NHS palpitations, reviewed March2026.

A blackout is important information even if recovery was rapid. Tell the clinician whether it occurred during activity and what a witness observed. A loss of consciousness should not be silently converted into a diagnosis of panic. The relevant service may need a distinct assessment of the blackout as well as the heartbeat symptoms. NHS fainting.

Rhythm medicines can also cause harm, including slowing the heart or worsening another rhythm in some circumstances. A stronger treatment is not automatically a safer response to an undiagnosed symptom. Ask how adverse effects will be recognized and what monitoring accompanies an established prescription. NHLBI arrhythmia treatment.

Important interactions

Make one list of prescriptions, cold or allergy products, energy products, supplements and recreational substances. Include exact labels and recent dose changes. NHLBI identifies some prescribed and over-the-counter medicines as possible arrhythmia contributors. This is a reason for product-specific review, not a universal instruction to discontinue everything. NHLBI arrhythmia causes.

If a medicine is already treating a diagnosed rhythm disorder, ask before adding an energy, weight-loss or sleep product. A combination may matter even when each item is sold separately. Tell the pharmacist about kidney disease and any other relevant illness, because the review should address the actual person and combination rather than the “natural” marketing category.

Who needs assessment

Recurrent or more frequent episodes, a known heart condition or a relevant family history warrant clinical review. The presence of a possible stress trigger does not remove that need. Describe changes from the usual pattern and make clear whether the symptom is occurring now or ended earlier. NHS palpitations, reviewed March2026.

An ECG records electrical activity. Depending on the question and frequency of symptoms, clinicians may choose ambulatory recording such as a Holter or longer-term recorder. These are not interchangeable shopping products, and everyone does not need an implant. Ask what the proposed recording aims to capture and how a result will be reviewed. NHLBI arrhythmia diagnosis.

Targeted blood tests or heart imaging may be relevant when another cause or structural condition is suspected. A rhythm recording, a thyroid test and an image answer different questions. The testing plan should explain the question each is intended to resolve rather than treating a large bundle as automatic reassurance. NHLBI arrhythmia diagnosis.

Clinician-led use and follow-up

Ask whether the clinician has documented a rhythm or is still investigating a symptom. Retain the name of an established diagnosis and the relevant recording when available. This makes future conversations more precise than saying only that a medicine was once given for “a fast heart.”

If monitoring is arranged, clarify how to mark an event, what information to record and how to return the device. Ask what to do if the symptoms become urgent while wearing it. Monitoring is a diagnostic activity, not a reason to wait through a serious new event because the device is already recording.

The follow-up plan should specify who communicates the findings, what happens if the recording misses an episode and when to seek renewed advice. No rhythm-medicine dose, supplement regimen, home vagal manoeuvre or personal pulse cutoff is provided here. A recorded finding and an individualized discussion should precede a treatment decision.

Animal and in-vitro evidence

Cell and animal experiments on vessel function or cardiac stress can suggest mechanisms. They do not establish safe human dosing, symptom improvement or fewer serious events. A laboratory preparation and a retail product may differ in composition, absorption and exposure. No animal or in-vitro result contributes to the independent clinical verdict in this guide.

Funding and source roles

Rhythm monitoring, drug treatment, ablation, implanted devices and stimulant or supplement products have different revenue incentives. Public-source diagnostic education is used for attributed context; no manufacturer-supported outcome estimate determines a treatment verdict.

The symptom has no corporate owner. Medicines, diagnostics, devices, procedures and marketed supplements create different revenue incentives. This describes financial interests rather than misconduct. Funding tier evaluates proximity to the subject; A–D credibility assesses transparency, accuracy incentives and remaining uncertainty. An unresolved link stays unresolved, and a provisional public-information label does not clear the trials behind it.

Frequently asked questions

Do palpitations always mean an arrhythmia? No. They describe a sensation; assessment determines its cause. NHS palpitations, reviewed March2026.

Can an arrhythmia occur without symptoms? Yes. Some are found during other assessments. NHLBI arrhythmia symptoms.

Why might a clinician suggest a longer recording? Intermittent episodes may require a method matched to their frequency. NHLBI arrhythmia diagnosis.

Should I start magnesium for a fluttering heartbeat? This guide does not establish a universal supplement indication. A confirmed deficiency and an undiagnosed symptom are different problems.

Sources and funding notes

• NHS palpitations, reviewed March2026 — Actual March 2026 symptom definition, triggers and emergency-versus-review advice.
• NHLBI arrhythmias — Rhythm-disorder framework and symptom/diagnosis distinction.
• NHLBI arrhythmia symptoms — Actual arrhythmia symptoms and potentially silent rhythms.
• NHLBI arrhythmia causes — Actual electrical mechanisms and medication/illness triggers.
• NHLBI arrhythmia diagnosis — Actual ECG, ambulatory monitoring, targeted blood-test and genetic roles.
• NHLBI arrhythmia treatment — Treatment categories and medicine risks, not a personal or exhaustive 2026 regimen.
• NHLBI living with arrhythmia — Clinician-led follow-up and medicines context.
• NHS fainting — Associated loss-of-consciousness assessment context.
• NHLBI budget — Financial provenance only.
• NHLBI Gift Fund — Financial provenance only.
• NHS national website funding policy — Financial provenance only.

Original clinical pages and their relevant financial disclosures were opened. Actual March17,2026 NHS palpitations original and full NHLBI diagnostic, cause and treatment bodies were read. NHS specifies ongoing palpitations that do not go away OR associated red-flag symptoms; the guide preserves that wording. March2022 NHLBI treatment education is clinical context, not an exhaustive2026 regimen or personal manoeuvre instruction. Guidance, classification, emergency education and independent efficacy are distinct source roles. A full systematic review, complete society donor audit and author-by-author clearance of original treatment trials were not completed.

Last reviewed: October 4, 2026. Educational information, not a diagnosis or personal treatment plan. Use your local emergency service for an emergency.